
|Articles|May 30, 2023
POLL: Do You Feel Comfortable Prescribing Adalimumab Biosimilars?
Author(s)Dermatology Times Staff
Click here to answer this week's poll.
Advertisement
Do you feel comfortable prescribing adalimumab biosimilars?
Do you have more thoughts on adalimumab biosimilars? Email us at
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Demonstrates Positive Effects on TCS Use, Growth in Pediatric Patients
2
Topical and Systemic Tools Expand Options for Hair Loss, Pigmentary Disorders, and Hand Eczema
3
Pilot Study Tests Oral NAC as Adjunct in Vitiligo Therapy
4
Brian Kim, MD, MTR, FAAD, on the Power of Focus in Research
5


















